Literature DB >> 2221525

Castor bean intoxication.

K R Challoner1, M M McCarron.   

Abstract

We report the cases of a child who ingested two or more castor beans and two adults who each ingested four beans. All three patients developed severe gastroenteritis and recovered without sequelae after receiving IV fluids. The literature contains reports of 424 cases of castor bean intoxication. Symptoms of intoxication include acute gastroenteritis, fluid and electrolyte depletion, gastrointestinal bleeding, hemolysis, and hypoglycemia. Delayed cytotoxicity has not been reported. Of the 424 patients, 14 died (mortality rates: 8.1% of untreated and 0.4% of treated). Deaths were due to hypovolemic shock. Recommended treatment for asymptomatic patients who have chewed one or more raw beans is emergency department evaluation, gastric decontamination, administration of activated charcoal, observation until four to six hours after ingestion, and discharge instructions to return if symptoms develop. After decontamination and activated charcoal, symptomatic patients require hospitalization for treatment with IV fluids, supportive care, and monitoring for hypoglycemia, hemolysis, and complications of hypovolemia. Monitoring for delayed cytotoxicity is unnecessary. Castor beans and their dust are highly allergenic and may cause anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221525     DOI: 10.1016/s0196-0644(05)81525-2

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  15 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screen.

Authors:  Paul G Wahome; Yan Bai; Lori M Neal; Jon D Robertus; Nicholas J Mantis
Journal:  Toxicon       Date:  2010-03-27       Impact factor: 3.033

3.  A case of castor bean poisoning.

Authors:  Faisal A Al-Tamimi; Ahmad E M Hegazi
Journal:  Sultan Qaboos Univ Med J       Date:  2008-03

4.  Evaluation of ricinine, a ricin biomarker, from a non-lethal castor bean ingestion.

Authors:  Elizabeth I Hamelin; Rudolph C Johnson; John D Osterloh; David J Howard; Jerry D Thomas
Journal:  J Anal Toxicol       Date:  2012-09-26       Impact factor: 3.367

Review 5.  Treatment of neuroterrorism.

Authors:  Katharina M Busl; Thomas P Bleck
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 6.  Ricinus communis intoxications in human and veterinary medicine-a summary of real cases.

Authors:  Sylvia Worbs; Kernt Köhler; Diana Pauly; Marc-André Avondet; Martin Schaer; Martin B Dorner; Brigitte G Dorner
Journal:  Toxins (Basel)       Date:  2011-10-24       Impact factor: 4.546

Review 7.  A systematic review of the reporting of adverse events associated with medical herb use among children.

Authors:  Paula Gardiner; Denise Adams; Amanda C Filippelli; Hafsa Nasser; Robert Saper; Laura White; Sunita Vohra
Journal:  Glob Adv Health Med       Date:  2013-03

8.  Simultaneous detection of ricin and abrin DNA by real-time PCR (qPCR).

Authors:  Eva Felder; Ilona Mossbrugger; Mirko Lange; Roman Wölfel
Journal:  Toxins (Basel)       Date:  2012-08-31       Impact factor: 4.546

9.  Bayesian integration of isotope ratio for geographic sourcing of castor beans.

Authors:  Bobbie-Jo Webb-Robertson; Helen Kreuzer; Garret Hart; James Ehleringer; Jason West; Gary Gill; Douglas Duckworth
Journal:  J Biomed Biotechnol       Date:  2012-07-15

10.  Ricin crosses polarized human intestinal cells and intestines of ricin-gavaged mice without evident damage and then disseminates to mouse kidneys.

Authors:  Alyssa D Flora; Louise D Teel; Mark A Smith; James F Sinclair; Angela R Melton-Celsa; Alison D O'Brien
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.